Cambridge Investment Research Advisors
VTGN icon

Cambridge Investment Research Advisors’s VistaGen Therapeutics VTGN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-852
Closed -$3K – 3301
2023
Q1 		$3K Sell
852
-39
-4% -$137 ﹤0.01% 3145
2022
Q4 		$3K Buy
891
+540
+154% +$1.82K ﹤0.01% 3093
2022
Q3 		$2K Buy
+351
New +$2K ﹤0.01% 3047